Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 5628404, 11 pages
http://dx.doi.org/10.1155/2016/5628404
Review Article

Exosomes and Exosomal miRNA in Respiratory Diseases

1Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
2Institute of Medical Biotechnology, Molecular Medicine Department, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
3Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, Netherlands
4Airways Disease Section, National Heart & Lung Institute, Imperial College London, London, UK
5Nutricia Research Centre for Specialized Nutrition, Utrecht, Netherlands
6Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, USA
7Division of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Miami Leonard M. Miller School of Medicine, Miami, FL, USA

Received 20 June 2016; Accepted 28 August 2016

Academic Editor: Yaozu Xiang

Copyright © 2016 Shamila D. Alipoor et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Mayeux, “Biomarkers: potential uses and limitations,” NeuroRx, vol. 1, no. 2, pp. 182–188, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Gerstein and W. Krebs, “A database of macromolecular motions,” Nucleic Acids Research, vol. 26, no. 18, pp. 4280–4290, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Angulo, E. Lecuona, and J. I. Sznajder, “Role of MicroRNAs in lung disease,” Archivos de Bronconeumología, vol. 48, no. 9, pp. 325–330, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Sessa and A. Hata, “Role of microRNAs in lung development and pulmonary diseases,” Pulmonary Circulation, vol. 3, no. 2, pp. 315–328, 2013. View at Publisher · View at Google Scholar
  5. T. A. Farazi, J. I. Hoell, P. Morozov, and T. Tuschl, “MicroRNAs in human cancer,” in MicroRNA Cancer Regulation, U. Schmitz, O. Wolkenhauer, and J. Vera, Eds., vol. 774 of Advances in Experimental Medicine and Biology, pp. 1–20, Springer, Berlin, Germany, 2013. View at Publisher · View at Google Scholar
  6. J. T. Mendell and E. N. Olson, “MicroRNAs in stress signaling and human disease,” Cell, vol. 148, no. 6, pp. 1172–1187, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Booton and M. A. Lindsay, “Emerging role of microRNAs and long noncoding RNAs in respiratory disease,” Chest, vol. 146, no. 1, pp. 193–204, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. K. U. Tüfekci, M. G. Öner, R. L. J. Meuwissen, and Ş. Genç, “The role of microRNAs in human diseases,” Methods in Molecular Biology, vol. 1107, pp. 33–50, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Cherni and G. J. Weiss, “miRNAs in lung cancer: large roles for small players,” Future Oncology, vol. 7, no. 9, pp. 1045–1055, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Hu, K. M. Drescher, and X.-M. Chen, “Exosomal miRNAs: biological properties and therapeutic potential,” Frontiers in Genetics, vol. 3, article 56, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Cheng, R. A. Sharples, B. J. Scicluna, and A. F. Hill, “Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood,” Journal of Extracellular Vesicles, vol. 3, 2014. View at Publisher · View at Google Scholar
  12. N. T. Eissa, “The exosome in lung diseases: message in a bottle,” Journal of Allergy and Clinical Immunology, vol. 131, no. 3, pp. 904–905, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Lin, J. Li, B. Huang et al., “Exosomes: novel biomarkers for clinical diagnosis,” The Scientific World Journal, vol. 2015, Article ID 657086, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Raposo and W. Stoorvogel, “Extracellular vesicles: exosomes, microvesicles, and friends,” The Journal of Cell Biology, vol. 200, no. 4, pp. 373–383, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. N. A. Kruh-Garcia, J. S. Schorey, and K. M. Dobos, Exosomes: New Tuberculosis Biomarkers-Prospects From the Bench to the Clinic, INTECH, Rijeka, Croatia, 2012.
  16. S. Bhatnagar and J. S. Schorey, “Exosomes released from infected macrophages contain Mycobacterium avium glycopeptidolipids and are proinflammatory,” The Journal of Biological Chemistry, vol. 282, no. 35, pp. 25779–25789, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Kourembanas, “Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy,” Annual Review of Physiology, vol. 77, pp. 13–27, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. C.-H. Kim, M.-J. Hong, S.-D. Park et al., “Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12,” Cancer Immunology, Immunotherapy, vol. 55, no. 11, pp. 1309–1319, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. P. P. Singh, V. L. Smith, P. C. Karakousis, and J. S. Schorey, “Exosomes isolated from mycobacteria-infected mice or cultured macrophages can recruit and activate immune cells in vitro and in vivo,” Journal of Immunology, vol. 189, no. 2, pp. 777–785, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. P. P. Singh, C. LeMaire, J. C. Tan, E. Zeng, and J. S. Schorey, “Exosomes released from m.tuberculosis infected cells can suppress ifn-γ mediated activation of naïve macrophages,” PLoS ONE, vol. 6, no. 4, article e18564, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Krek, D. Grün, M. N. Poy et al., “Combinatorial microRNA target predictions,” Nature Genetics, vol. 37, no. 5, pp. 495–500, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Valadi, K. Ekström, A. Bossios, M. Sjöstrand, J. J. Lee, and J. O. Lötvall, “Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells,” Nature Cell Biology, vol. 9, no. 6, pp. 654–659, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Mathivanan and R. J. Simpson, “ExoCarta: a compendium of exosomal proteins and RNA,” Proteomics, vol. 9, no. 21, pp. 4997–5000, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. J. A. Tickner, A. J. Urquhart, S.-A. Stephenson, D. J. Richard, and K. J. O'Byrne, “Functions and therapeutic roles of exosomes in cancer,” Frontiers in Oncology, vol. 4, article 127, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Sun, B. Kalionis, G. Lv, S. Xia, and W. Gao, “Role of exosomal noncoding RNAs in lung carcinogenesis,” BioMed Research International, vol. 2015, article 125807, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Eldh, “Exosomes and Exosomal RNA-A Way of Cell-to-Cell Communication,” 2013.
  27. R. H. Staals and G. J. Pruijn, “The human exosome and disease,” in RNA Exosome, pp. 132–142, Springer, 2010. View at Google Scholar
  28. W. L. Beatty, E. R. Rhoades, H. J. Ullrich, D. Chatterjee, J. E. Heuser, and D. G. Russell, “Trafficking and release of mycobacterial lipids from infected macrophages,” Traffic, vol. 1, no. 3, pp. 235–247, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. R. J. Simpson, J. W. E. Lim, R. L. Moritz, and S. Mathivanan, “Exosomes: proteomic insights and diagnostic potential,” Expert Review of Proteomics, vol. 6, no. 3, pp. 267–283, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. A. I. Masyuk, T. V. Masyuk, and N. F. LaRusso, “Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases,” Journal of Hepatology, vol. 59, no. 3, pp. 621–625, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. K. R. Qazi, P. T. Paredes, B. Dahlberg, J. Grunewald, A. Eklund, and S. Gabrielsson, “Proinflammatory exosomes in bronchoalveolar lavage fluid of patients with sarcoidosis,” Thorax, vol. 65, no. 11, pp. 1016–1024, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Skog, T. Würdinger, S. van Rijn et al., “Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers,” Nature Cell Biology, vol. 10, no. 12, pp. 1470–1476, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. M. E. T. Tesselaar, F. P. H. T. M. Romijn, I. K. Van Der Linden, F. A. Prins, R. M. Bertina, and S. Osanto, “Microparticle-associated tissue factor activity: a link between cancer and thrombosis?” Journal of Thrombosis and Haemostasis, vol. 5, no. 3, pp. 520–527, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. N. A. Kruh-Garcia, L. M. Wolfe, L. H. Chaisson et al., “Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS,” PLoS ONE, vol. 9, no. 7, Article ID e103811, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. J.-J. Wang, C. Chen, P.-F. Xie, Y. Pan, Y.-H. Tan, and L.-J. Tang, “Proteomic analysis and immune properties of exosomes released by macrophages infected with Mycobacterium avium,” Microbes and Infection, vol. 16, no. 4, pp. 283–291, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Liu, C. Zhang, Z. Hu et al., “A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis,” European Journal of Cancer, vol. 47, no. 5, pp. 784–791, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. G. A. Calin and C. M. Croce, “MicroRNA signatures in human cancers,” Nature Reviews Cancer, vol. 6, no. 11, pp. 857–866, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. D. M. Smalley, N. E. Sheman, K. Nelson, and D. Theodorescu, “Isolation and identification of potential urinary microparticle biomarkers of bladder cancer,” Journal of Proteome Research, vol. 7, no. 5, pp. 2088–2096, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Khalyfa and D. Gozal, “Exosomal miRNAs as potential biomarkers of cardiovascular risk in children,” Journal of Translational Medicine, vol. 12, article 162, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Mittelbrunn, C. Gutiérrez-Vázquez, C. Villarroya-Beltri et al., “Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells,” Nature Communications, vol. 2, no. 1, article 282, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. R. M. Johnstone, “Exosomes biological significance: a concise review,” Blood Cells, Molecules, and Diseases, vol. 36, no. 2, pp. 315–321, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Delcayre, H. Shu, and J.-B. Le Pecq, “Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway,” Expert Review of Anticancer Therapy, vol. 5, no. 3, pp. 537–547, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. J. De Toro, L. Herschlik, C. Waldner, and C. Mongini, “Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications,” Frontiers in Immunology, vol. 6, article 203, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Andre, B. Escudier, E. Angevin, T. Tursz, and L. Zitvogel, “Exosomes for cancer immunotherapy,” Annals of Oncology, vol. 15, no. 4, pp. iv141–iv144, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. B. Escudier, T. Dorval, N. Chaput et al., “Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial,” Journal of Translational Medicine, vol. 3, no. 1, article 10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Lugini, S. Cecchetti, V. Huber et al., “Immune surveillance properties of human NK cell-derived exosomes,” The Journal of Immunology, vol. 189, no. 6, pp. 2833–2842, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Théry, M. Ostrowski, and E. Segura, “Membrane vesicles as conveyors of immune responses,” Nature Reviews Immunology, vol. 9, no. 8, pp. 581–593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Viaud, M. Terme, C. Flament et al., “Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Rα,” PLoS ONE, vol. 4, no. 3, article e4942, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. T. I. Näslund, U. Gehrmann, K. R. Qazi, M. C. I. Karlsson, and S. Gabrielsson, “Dendritic cell-derived exosomes need to activate both T and B cells to induce antitumor immunity,” The Journal of Immunology, vol. 190, no. 6, pp. 2712–2719, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. X. Gu, U. Erb, M. W. Büchler, and M. Zöller, “Improved vaccine efficacy of tumor exosome compared to tumor lysate loaded dendritic cells in mice,” International Journal of Cancer, vol. 136, no. 4, pp. E74–E84, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Zöller, “Exosomes in cancer disease,” in Cancer Gene Profiling: Methods and Protocols, R. Grützmann and C. Pilarsky, Eds., vol. 1381 of Methods in Molecular Biology, pp. 111–149, 2016. View at Publisher · View at Google Scholar
  52. Y. Zhang and X.-F. Wang, “A niche role for cancer exosomes in metastasis,” Nature Cell Biology, vol. 17, no. 6, pp. 709–711, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Sceneay, M. J. Smyth, and A. Möller, “The pre-metastatic niche: finding common ground,” Cancer and Metastasis Reviews, vol. 32, no. 3-4, pp. 449–464, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Hoshino, B. Costa-Silva, T.-L. Shen et al., “Tumour exosome integrins determine organotropic metastasis,” Nature, vol. 527, no. 7578, pp. 329–335, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. H. S. Chahar, X. Bao, and A. Casola, “Exosomes and their role in the life cycle and pathogenesis of RNA viruses,” Viruses, vol. 7, no. 6, pp. 3204–3225, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. E. van der Pol, A. N. Böing, P. Harrison, A. Sturk, and R. Nieuwland, “Classification, functions, and clinical relevance of extracellular vesicles,” Pharmacological Reviews, vol. 64, no. 3, pp. 676–705, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. N. A. Kruh-Garcia, L. M. Wolfe, and K. M. Dobos, “Deciphering the role of exosomes in tuberculosis,” Tuberculosis, vol. 95, no. 1, pp. 26–30, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. P. K. Anand, E. Anand, C. K. E. Bleck, E. Anes, and G. Griffiths, “Exosomal hsp70 induces a pro-inflammatory response to foreign particles including mycobacteria,” PLoS ONE, vol. 5, no. 4, Article ID e10136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. D.-H. Hsu, P. Paz, G. Villaflor et al., “Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides,” Journal of Immunotherapy, vol. 26, no. 5, pp. 440–450, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. N. Chaput, N. E. C. Schartz, F. Andre, and L. Zitvogel, “Exosomes for immunotherapy of cancer,” Advances in Experimental Medicine and Biology, vol. 532, pp. 215–221, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. F. Andre, M. Andersen, J. Wolfers et al., “Exosomes in cancer immunotherapy: preclinical data,” Advances in Experimental Medicine and Biology, vol. 495, pp. 349–354, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. Fujita, N. Kosaka, J. Araya, K. Kuwano, and T. Ochiya, “Extracellular vesicles in lung microenvironment and pathogenesis,” Trends in Molecular Medicine, vol. 21, no. 9, pp. 533–542, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. M. C. Rose and J. A. Voynow, “Respiratory tract mucin genes and mucin glycoproteins in health and disease,” Physiological Reviews, vol. 86, no. 1, pp. 245–278, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. E. Bourdonnay, Z. Zasłona, L. R. K. Penke et al., “Transcellular delivery of vesicular SOCS proteins from macrophages to epithelial cells blunts inflammatory signaling,” The Journal of Experimental Medicine, vol. 212, no. 5, pp. 729–742, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. N. Ismail, Y. Wang, D. Dakhlallah et al., “Macrophage microvesicles induce macrophage differentiation and miR-223 transfer,” Blood, vol. 121, no. 6, pp. 984–995, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. C. Cordazzo, S. Petrini, T. Neri et al., “Rapid shedding of proinflammatory microparticles by human mononuclear cells exposed to cigarette smoke is dependent on Ca2+ mobilization,” Inflammation Research, vol. 63, no. 7, pp. 539–547, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. D. D. Taylor and C. Gercel-Taylor, “MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer,” Gynecologic Oncology, vol. 110, no. 1, pp. 13–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Xie, N. W. Todd, Z. Liu et al., “Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer,” Lung Cancer, vol. 67, no. 2, pp. 170–176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. C. Lässer, “Exosomal RNA as biomarkers and the therapeutic potential of exosome vectors,” Expert Opinion on Biological Therapy, vol. 12, no. 1, pp. S189–S197, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. J. S. Schorey, Y. Cheng, P. P. Singh, and V. L. Smith, “Exosomes and other extracellular vesicles in host-pathogen interactions,” EMBO Reports, vol. 16, no. 1, pp. 24–43, 2015. View at Publisher · View at Google Scholar · View at Scopus
  71. A. A. Velayati, T. Abeel, T. Shea et al., “Populations of latent Mycobacterium tuberculosis lack a cell wall: isolation, visualization, and whole-genome characterization,” International Journal of Mycobacteriology, vol. 5, no. 1, pp. 66–73, 2016. View at Publisher · View at Google Scholar · View at Scopus
  72. P. K. Giri, N. A. Kruh, K. M. Dobos, and J. S. Schorey, “Proteomic analysis identifies highly antigenic proteins in exosomes from M. tuberculosis-infected and culture filtrate protein-treated macrophages,” Proteomics, vol. 10, no. 17, pp. 3190–3202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. S. M. Fortune, A. Solache, A. Jaeger et al., “Mycobacterium tuberculosis inhibits macrophage responses to IFN-γ through myeloid differentiation factor 88-dependent and -independent mechanisms,” The Journal of Immunology, vol. 172, no. 10, pp. 6272–6280, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. L. Furci, E. Schena, P. Miotto, and D. M. Cirillo, “Alteration of human macrophages microRNA expression profile upon infection with Mycobacterium tuberculosis,” International Journal of Mycobacteriology, vol. 2, no. 3, pp. 128–134, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. P. P. Singh, L. Li, and J. S. Schorey, “Exosomal RNA from Mycobacterium tuberculosis-infected cells is functional in recipient macrophages,” Traffic, vol. 16, no. 6, pp. 555–571, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Pearson, “Is the primary mechanism underlying COPD: inflammation or ischaemia?” COPD, vol. 10, no. 4, pp. 536–541, 2013. View at Publisher · View at Google Scholar · View at Scopus
  77. P. J. Barnes, S. D. Shapiro, and R. A. Pauwels, “Chronic obstructive pulmonary disease: molecular and cellular mechanisms,” European Respiratory Journal, vol. 22, no. 4, pp. 672–688, 2003. View at Publisher · View at Google Scholar · View at Scopus
  78. W. MacNee and K. Donaldson, “Mechanism of lung injury caused by PM10 and ultrafine particles with special reference to COPD,” The European Respiratory Journal. Supplement, vol. 40, pp. 47s–51s, 2003. View at Google Scholar
  79. A. Di Stefano, G. Caramori, F. L. M. Ricciardolo, A. Capelli, I. M. Adcock, and C. F. Donner, “Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview,” Clinical and Experimental Allergy, vol. 34, no. 8, pp. 1156–1167, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. A. Kratzer, H. W. Chu, J. Salys et al., “Endothelial cell adhesion molecule CD146: implications for its role in the pathogenesis of COPD,” The Journal of Pathology, vol. 230, no. 4, pp. 388–398, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. T. Takahashi and H. Kubo, “The role of microparticles in chronic obstructive pulmonary disease,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 9, pp. 303–314, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. C.-J. Li, Y. Liu, Y. Chen, D. Yu, K. J. Williams, and M.-L. Liu, “Novel proteolytic microvesicles released from human macrophages after exposure to tobacco smoke,” American Journal of Pathology, vol. 182, no. 5, pp. 1552–1562, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. H.-G. Moon, S.-H. Kim, J. Gao et al., “CCN1 secretion and cleavage regulate the lung epithelial cell functions after cigarette smoke,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 307, no. 4, pp. L326–L337, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. L. P. Chew, D. Huttenlocher, K. Kedem, and J. Kleinberg, “Fast detection of common geometric substructure in proteins,” Journal of Computational Biology, vol. 6, no. 3-4, pp. 313–325, 1999. View at Publisher · View at Google Scholar · View at Scopus
  85. Y. Fujita, J. Araya, and T. Ochiya, “Extracellular vesicles in smoking-related lung diseases,” Oncotarget, vol. 6, no. 41, pp. 43144–43145, 2015. View at Publisher · View at Google Scholar · View at Scopus
  86. E. Letsiou, S. Sammani, W. Zhang et al., “Pathologic mechanical stress and endotoxin exposure increases lung endothelial microparticle shedding,” American Journal of Respiratory Cell and Molecular Biology, vol. 52, no. 2, pp. 193–204, 2015. View at Publisher · View at Google Scholar · View at Scopus
  87. P. B. Sorroche, M. Fernández Acquier, O. López Jove et al., “Alpha-1 antitrypsin deficiency in COPD patients: a cross-sectional study,” Archivos de Bronconeumología, vol. 51, no. 11, pp. 539–543, 2015. View at Publisher · View at Google Scholar
  88. A. D. Lockett, M. B. Brown, N. Santos-Falcon et al., “Active trafficking of alpha 1 antitrypsin across the lung endothelium,” PLoS ONE, vol. 9, no. 4, Article ID e93979, 2014. View at Publisher · View at Google Scholar · View at Scopus
  89. S. S. Sohal and E. H. Walters, “Role of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD),” Respiratory Research, vol. 14, article 120, 2013. View at Publisher · View at Google Scholar · View at Scopus
  90. Q. Wang, Y. Wang, Y. Zhang, Y. Zhang, and W. Xiao, “The role of uPAR in epithelial-mesenchymal transition in small airway epithelium of patients with chronic obstructive pulmonary disease,” Respiratory Research, vol. 14, no. 1, article 67, 2013. View at Publisher · View at Google Scholar · View at Scopus
  91. L. J. Vella, “The emerging role of exosomes in epithelial-mesenchymal-transition in cancer,” Frontiers in Oncology, vol. 4, article 361, 2014. View at Publisher · View at Google Scholar · View at Scopus
  92. S. Bozinovski, R. Vlahos, D. Anthony et al., “COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link,” British Journal of Pharmacology, vol. 173, no. 4, pp. 638–648, 2016. View at Publisher · View at Google Scholar · View at Scopus
  93. J. P. De-Torres, D. O. Wilson, P. Sanchez-Salcedo et al., “Lung cancer in patients with chronic obstructive pulmonary disease: development and validation of the COPD lung cancer screening score,” American Journal of Respiratory and Critical Care Medicine, vol. 191, no. 3, pp. 285–291, 2015. View at Publisher · View at Google Scholar · View at Scopus
  94. P. J. Barnes and I. M. Adcock, “Chronic obstructive pulmonary disease and lung cancer: a lethal association,” American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 8, pp. 866–867, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. J. de Torres, J. Marin, C. Casanova et al., “Lung cancer in patients with COPD: incidence and predicting factors,” European Respiratory Journal, vol. 38, supplement 55, Article ID p2728, 2011. View at Google Scholar
  96. M. J. Evans, M. V. Fanucchi, C. G. Plopper, and D. M. Hyde, “Postnatal development of the lamina reticularis in primate airways,” The Anatomical Record, vol. 293, no. 6, pp. 947–954, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. M. J. Evans, L. S. Van Winkle, M. V. Fanucchi, and C. G. Plopper, “The attenuated fibroblast sheath of the respiratory tract epithelial-mesenchymal trophic unit,” American Journal of Respiratory Cell and Molecular Biology, vol. 21, no. 6, pp. 655–657, 1999. View at Publisher · View at Google Scholar · View at Scopus
  98. A. Donaldson, S. A. Natanek, A. Lewis et al., “Increased skeletal muscle-specific microRNA in the blood of patients with COPD,” Thorax, vol. 68, no. 12, pp. 1140–1149, 2013. View at Publisher · View at Google Scholar · View at Scopus
  99. H. Burke, C. M. Spalluto, D. Cellura, K. J. Staples, and T. M. Wilkinson, “Role of exosomal microRNA in driving skeletal muscle wasting in COPD,” European Respiratory Journal, vol. 46, supplement 59, 2015. View at Publisher · View at Google Scholar
  100. J. Maertzdorf, J. Weiner III, H.-J. Mollenkopf et al., “Common patterns and disease-related signatures in tuberculosis and sarcoidosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 20, pp. 7853–7858, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. E. D. Crouser, M. W. Julian, M. Crawford et al., “Differential expression of microRNA and predicted targets in pulmonary sarcoidosis,” Biochemical and Biophysical Research Communications, vol. 417, no. 2, pp. 886–891, 2012. View at Publisher · View at Google Scholar · View at Scopus
  102. A. Jazwa, L. Kasper, M. Bak et al., “Differential inflammatory microRNA and cytokine expression in pulmonary sarcoidosis,” Archivum Immunologiae et Therapiae Experimentalis, vol. 63, no. 2, pp. 139–146, 2015. View at Publisher · View at Google Scholar · View at Scopus
  103. A. A. Abd-El-Fattah, N. A. H. Sadik, O. G. Shaker, and M. L. Aboulftouh, “Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia,” Cell Biochemistry and Biophysics, vol. 67, no. 3, pp. 875–884, 2013. View at Publisher · View at Google Scholar · View at Scopus
  104. A. Kishore, Z. Navratilova, V. Kolek, and M. Petrek, “Detection of exosomal miRNA in pulmonary sarcoidosis,” European Respiratory Journal, vol. 44, supplement 58, article 48, 2014. View at Google Scholar
  105. B. N. Lambrecht and H. Hammad, “The immunology of asthma,” Nature Immunology, vol. 16, no. 1, pp. 45–56, 2015. View at Publisher · View at Google Scholar · View at Scopus
  106. Y. Fujita, Y. Yoshioka, S. Ito, J. Araya, K. Kuwano, and T. Ochiya, “Intercellular communication by extracellular vesicles and their MicroRNAs in Asthma,” Clinical Therapeutics, vol. 36, no. 6, pp. 873–881, 2014. View at Publisher · View at Google Scholar · View at Scopus
  107. C. Admyre, E. Telemo, N. Almqvist et al., “Exosomes—nanovesicles with possible roles in allergic inflammation,” Allergy, vol. 63, no. 4, pp. 404–408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. C. Admyre, J. Grunewald, J. Thyberg et al., “Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid,” European Respiratory Journal, vol. 22, no. 4, pp. 578–583, 2003. View at Publisher · View at Google Scholar · View at Scopus
  109. C. Mazzeo, J. A. Cañas, M. P. Zafra et al., “Exosome secretion by eosinophils: a possible role in asthma pathogenesis,” Journal of Allergy and Clinical Immunology, vol. 135, no. 6, pp. 1603–1613, 2015. View at Publisher · View at Google Scholar · View at Scopus
  110. N. Prado, E. G. Marazuela, E. Segura et al., “Exosomes from bronchoalveolar fluid of tolerized mice prevent allergic reaction,” The Journal of Immunology, vol. 181, no. 2, pp. 1519–1525, 2008. View at Publisher · View at Google Scholar · View at Scopus
  111. P. Torregrosa Paredes, J. Esser, C. Admyre et al., “Bronchoalveolar lavage fluid exosomes contribute to cytokine and leukotriene production in allergic asthma,” Allergy, vol. 67, no. 7, pp. 911–919, 2012. View at Publisher · View at Google Scholar · View at Scopus
  112. A. Kulshreshtha, T. Ahmad, A. Agrawal, and B. Ghosh, “Proinflammatory role of epithelial cell–derived exosomes in allergic airway inflammation,” Journal of Allergy and Clinical Immunology, vol. 131, no. 4, pp. 1194–1203.e14, 2013. View at Publisher · View at Google Scholar · View at Scopus
  113. B. Levänen, N. R. Bhakta, P. T. Paredes et al., “Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patients,” The Journal of Allergy & Clinical Immunology, vol. 131, no. 3, pp. 894–903.e8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  114. C. Lee, S. A. Mitsialis, M. Aslam et al., “Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension,” Circulation, vol. 126, no. 22, pp. 2601–2611, 2012. View at Publisher · View at Google Scholar · View at Scopus
  115. H. Moon, Y. Cao, J. Yang, J. H. Lee, H. S. Choi, and Y. Jin, “Lung epithelial cell-derived extracellular vesicles activate macrophage-mediated inflammatory responses via ROCK1 pathway,” Cell Death and Disease, vol. 6, no. 12, article e2016, 2015. View at Publisher · View at Google Scholar
  116. B. Ley, H. R. Collard, and T. E. King Jr., “Clinical course and prediction of survival in idiopathic pulmonary fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 4, pp. 431–440, 2011. View at Publisher · View at Google Scholar · View at Scopus
  117. P. Minnis, R. Kane, R. Anglin et al., “Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity,” European Respiratory Journal, vol. 46, supplement 59, Article ID PA3845, 2015. View at Publisher · View at Google Scholar
  118. C. Vituret, K. Gallay, M.-P. Confort et al., “Transfer of the cystic fibrosis transmembrane conductance regulator to human cystic fibrosis cells mediated by extracellular vesicles,” Human Gene Therapy, vol. 27, no. 2, pp. 166–183, 2016. View at Publisher · View at Google Scholar · View at Scopus
  119. C. Porro, S. Lepore, T. Trotta et al., “Isolation and characterization of microparticles in sputum from cystic fibrosis patients,” Respiratory Research, vol. 11, no. 1, article 94, 2010. View at Publisher · View at Google Scholar · View at Scopus
  120. T. Szul, P. E. Bratcher, K. B. Fraser et al., “Toll-like receptor 4 engagement mediates prolyl endopeptidase release from airway epithelia via exosomes,” American Journal of Respiratory Cell and Molecular Biology, vol. 54, no. 3, pp. 359–369, 2016. View at Publisher · View at Google Scholar
  121. G. Hu, A.-Y. Gong, A. L. Roth et al., “Release of luminal exosomes contributes to TLR4-mediated epithelial antimicrobial defense,” PLoS Pathogens, vol. 9, no. 4, Article ID e1003261, 2013. View at Publisher · View at Google Scholar · View at Scopus
  122. M. Kesimer and R. Gupta, “Physical characterization and profiling of airway epithelial derived exosomes using light scattering,” Methods, vol. 87, pp. 59–63, 2015. View at Publisher · View at Google Scholar · View at Scopus
  123. M. Arifuzzaman, P. Haridass, H. Dang et al., “Qualitative and quantitative changes of gel forming mucins and exosomes in response to infection and inflammation in the airways,” in C60. All About Cystic Fibrosis, p. A5565, American Thoracic Society International Conference Abstracts, 2016. View at Google Scholar
  124. L. Huang, W. Ma, Y. Ma, D. Feng, H. Chen, and B. Cai, “Exosomes in mesenchymal stem cells, a new therapeutic strategy for cardiovascular diseases?” International Journal of Biological Sciences, vol. 11, no. 2, pp. 238–245, 2015. View at Publisher · View at Google Scholar · View at Scopus
  125. J. G. Wilson, K. D. Liu, H. Zhuo et al., “Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial,” The Lancet Respiratory Medicine, vol. 3, no. 1, pp. 24–32, 2015. View at Publisher · View at Google Scholar · View at Scopus
  126. Y.-G. Zhu, X.-M. Feng, J. Abbott et al., “Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice,” STEM CELLS, vol. 32, no. 1, pp. 116–125, 2014. View at Publisher · View at Google Scholar · View at Scopus
  127. M. A. Morse, J. Garst, T. Osada et al., “A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer,” Journal of Translational Medicine, vol. 3, no. 1, article 9, 2005. View at Publisher · View at Google Scholar · View at Scopus